Company: RCUS
Filing Date: 2025-02-18
Form Type: 424B5
Source: 0001193125-25-028669
Chunk: 50

Company: Arcus Biosciences, Inc.
Filing Date: 2025-02-18
Form: 424B5
Chunk 50
---
 by reference from reports that we file with the SEC, the form of any certificate of designation that contains the terms of the series of preferred stock we are offering. We will describe in the applicable prospectus supplement the terms of the series of preferred stock being offered, including, to the extent applicable:

| • |     | the title and stated value; |

| • |     | the number of shares we are offering; |

| • |     | the liquidation preference per share; |

| • |     | the purchase price; |

| • |     | the dividend rate, period and payment date and method of calculation for dividends; |

| • |     | whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will 
 accumulate;                                                                                                   |

| • |     | the procedures for any auction and remarketing, if applicable; |

| • |     | the provisions for a sinking fund, if applicable; |

| • |     | the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those 
 redemption and repurchase rights;                                                                                 |

| • |     | any listing of the preferred stock on any securities exchange or market; |

| • |     | whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, 
 or how it will be calculated, and the conversion period;                                                         |

| • |     | whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or 
 how it will be calculated, and the exchange period;                                                               |

| • |     | voting rights of the preferred stock; |

| • |     | preemptive rights, if any; |

| • |     | restrictions on transfer, sale or other assignment; |

| • |     | whether interests in the preferred stock will be represented by depositary shares; |

| • |     | a discussion of material United States federal income tax considerations applicable to the preferred stock; |

| • |     | the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, 
 dissolve or wind up our affairs;                                                                              |

| • |     | any limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with      
 the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and |

| • |     | any other specific terms, preferences,